AWM
AUPH icon

Accel Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Accel Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,045
Closed -$11.5K – 220
2023
Q1 		$11.5K Hold
1,045
– – ﹤0.01% 852
2022
Q4 		$4.51K Sell
1,045
-6,810
-87% -$39.5K ﹤0.01% 826
2022
Q3 		$59K Buy
7,855
+7,370
+1,520% +$63.8K 0.03% 331
2022
Q2 		$5K Hold
485
– – ﹤0.01% 801
2022
Q1 		$6K Hold
485
– – ﹤0.01% 774
2021
Q4 		$11K Buy
485
+135
+39% +$3.2K 0.01% 687
2021
Q3 		$8K Sell
350
-1,635
-82% -$25.9K 0.01% 670
2021
Q2 		$26K Buy
1,985
+1,500
+309% +$19.1K 0.02% 462
2021
Q1 		$6K Hold
485
– – ﹤0.01% 719
2020
Q4 		$7K Buy
+485
New +$7.06K 0.01% 662

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return